Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | DST-2970 + Prednisone |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| DST-2970 | DST2970|DST 2970 | Hormone - Anti-androgens 57 | DST-2970 is a solid dispersion formulation of abiraterone, which inhibits the cytochrome p450 family enzyme Cyp17a1 potentially leading to inhibition of testosterone production (NCI Drug Dictionary). | |
| Prednisone | Adasone | Dehydrocortisone | Adasone (prednisone) is a corticosteroid which functions as an immunosuppressant and anti-inflammatory agent and which may stimulate apoptosis in tumor cells (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04291664 | Phase I | Abiraterone + Prednisone DST-2970 + Prednisone | PK and Dose Escalation and Expansion Study of DST-2970 | Terminated | USA | 0 |